The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair

被引:40
作者
Wankell, M
Kaesler, S
Zhang, YQ
Florence, C
Werner, S
Duan, R
机构
[1] ETH Zurich, Inst Cell Biol, CH-8093 Zurich, Switzerland
[2] Human Genome Sci Inc, Rockville, MD 20850 USA
关键词
D O I
10.1677/joe.0.1710385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Follistatin is a secreted protein that binds activin in vitro and in vivo and thereby inhibits its biological functions. Recently, related human and murine genes, designated follistatin-related gene (FLRG), were identified, and their products were shown to bind activin with high affinity. In this study we further characterized the murine FLRG protein, and we analyzed its tissue-specific expression and regulation in comparison with those of follistatin. Transient expression of the mouse FLRG protein in COS-1 cells, revealed that the FLRG cDNA encodes a secreted glycoprotein. FLRG mRNA was expressed at high levels in the lung, the testis, the uterus and, particularly, the skin. Immunohistochemistry revealed the presence of FLRG in the basement membrane between the dermis and the epidermis and around blood vessels. FLRG mRNA expression was induced in keratinocytes by keratinocyte growth factor, epidermal growth factor and transforming growth factor-beta (1), and in fibroblasts by platelet-derived growth factor and epidermal growth factor. The induction was more rapid, but weaker, than that of follistatin. Most interestingly, both follistatin and FLRG were expressed during the wound healing process, but their distribution within the wound was different. The different expression pattern of FLRG and follistatin and their differential regulation suggest different functions of these activin-binding proteins iv vivo.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 30 条
[1]  
ALBANO RM, 1994, DEVELOPMENT, V120, P803
[2]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[3]  
Breit S, 2000, CANCER RES, V60, P4596
[4]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors [J].
deWinter, JP ;
tenDijke, P ;
deVries, CJM ;
vanAchterberg, TAE ;
Sugino, H ;
deWaele, P ;
Huylebroeck, D ;
Verschueren, K ;
vandenEijndenvanRaaij, AJM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 116 (01) :105-114
[7]   A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos [J].
Gamer, LW ;
Wolfman, NM ;
Celeste, AJ ;
Hattersley, G ;
Hewick, R ;
Rosen, V .
DEVELOPMENTAL BIOLOGY, 1999, 208 (01) :222-232
[8]   A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells - Endocytotic degradation of actin and its acceleration by follistatin associated with cell-surface heparan sulfate [J].
Hashimoto, O ;
Nakamura, T ;
Shoji, H ;
Shimasaki, S ;
Hayashi, Y ;
Sugino, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13835-13842
[9]   FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders [J].
Hayette, S ;
Gadoux, M ;
Martel, S ;
Bertrand, S ;
Tigaud, I ;
Magaud, JP ;
Rimokh, R .
ONCOGENE, 1998, 16 (22) :2949-2954
[10]   Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes [J].
Hubner, G ;
Werner, S .
EXPERIMENTAL CELL RESEARCH, 1996, 228 (01) :106-113